Bright Minds Biosciences Inc (DRUG) — Financial Flexibility Index
Bright Minds Biosciences Inc (DRUG) has a Financial Flexibility Index of -2.48x as of March 2026. Free cash flow of $-9.50 Million (operating CF $-9.50 Million minus capex $4.18) represents -2% of total liabilities ($3.83 Million). Check Bright Minds Biosciences Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bright Minds Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Bright Minds Biosciences Inc across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Bright Minds Biosciences Inc.
Annual Financial Flexibility Index for Bright Minds Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Bright Minds Biosciences Inc. Explore debt repayment capacity of Bright Minds Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.66x | $-8.69 Million | $-8.69 Million | $2.38 Million | ▼ -12.3% |
| 2024 | -3.26x | $-1.85 Million | $-1.85 Million | $568.26K | ▲ +87.0% |
| 2023 | -25.01x | $-7.02 Million | $-7.02 Million | $280.86K | ▼ -184.3% |
| 2022 | -8.80x | $-13.59 Million | $-13.59 Million | $1.54 Million | ▲ +23.2% |
| 2021 | -11.46x | $-7.32 Million | $-7.32 Million | $638.57K | ▼ -499.8% |
| 2020 | -1.91x | $-288.39K | $-288.39K | $150.92K | ▼ -67.0% |
| 2019 | -1.14x | $-42.01K | $-42.01K | $36.71K | — |